drugset / Trial / NCT05813626
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally advanced nasopharyngeal carcinoma
Timeline
- Start
- 2023-04-21
- Primary completion
- 2025-08-15
- Completion
- 2027-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 80 mg/m2 | Intravenous |
| Subject | Gemcitabine | Small molecule | 1 g | Intravenous |
| Subject | Toripalimab | Monoclonal antibody | 240 mg | — |